Personal tools

MCL coexpression mm9:2296: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002193!2.04e-19!48;UBERON:0002405!2.04e-19!48;UBERON:0002390!1.17e-18!45;UBERON:0003061!1.17e-18!45;UBERON:0004177!4.04e-17!29;UBERON:0005057!4.04e-17!29;UBERON:0000077!7.14e-17!35;UBERON:0003408!1.33e-13!24;UBERON:0002370!7.75e-13!23;UBERON:0000974!7.75e-13!23;UBERON:0004807!7.75e-13!23;UBERON:0005058!7.75e-13!23;UBERON:0003351!7.75e-13!23;UBERON:0009113!7.75e-13!23;UBERON:0003295!7.75e-13!23;UBERON:0009722!7.75e-13!23;UBERON:0005562!7.75e-13!23;UBERON:0007690!7.75e-13!23;UBERON:0006562!5.64e-12!24;UBERON:0001557!5.64e-12!24;UBERON:0001042!5.64e-12!24;UBERON:0008814!5.64e-12!24;UBERON:0009145!5.64e-12!24;UBERON:0001041!5.92e-11!80;UBERON:0001004!1.27e-10!42;UBERON:0003081!2.23e-10!87;UBERON:0000065!5.48e-10!41;UBERON:0000072!8.39e-10!27;UBERON:0004119!5.12e-09!118;UBERON:0000925!5.12e-09!118;UBERON:0006595!5.12e-09!118;UBERON:0001007!2.72e-08!116;UBERON:0001555!2.72e-08!116;UBERON:0007026!2.72e-08!116;UBERON:0004921!3.71e-08!114;UBERON:0005911!1.97e-07!69;UBERON:0000926!2.01e-07!120;UBERON:0004120!2.01e-07!120;UBERON:0006603!2.01e-07!120;UBERON:0002530!2.59e-07!65;UBERON:0000063!7.35e-07!35
|ontology_enrichment_uberon=UBERON:0002193!2.04e-19!48;UBERON:0002405!2.04e-19!48;UBERON:0002390!1.17e-18!45;UBERON:0003061!1.17e-18!45;UBERON:0004177!4.04e-17!29;UBERON:0005057!4.04e-17!29;UBERON:0000077!7.14e-17!35;UBERON:0003408!1.33e-13!24;UBERON:0002370!7.75e-13!23;UBERON:0000974!7.75e-13!23;UBERON:0004807!7.75e-13!23;UBERON:0005058!7.75e-13!23;UBERON:0003351!7.75e-13!23;UBERON:0009113!7.75e-13!23;UBERON:0003295!7.75e-13!23;UBERON:0009722!7.75e-13!23;UBERON:0005562!7.75e-13!23;UBERON:0007690!7.75e-13!23;UBERON:0006562!5.64e-12!24;UBERON:0001557!5.64e-12!24;UBERON:0001042!5.64e-12!24;UBERON:0008814!5.64e-12!24;UBERON:0009145!5.64e-12!24;UBERON:0001041!5.92e-11!80;UBERON:0001004!1.27e-10!42;UBERON:0003081!2.23e-10!87;UBERON:0000065!5.48e-10!41;UBERON:0000072!8.39e-10!27;UBERON:0004119!5.12e-09!118;UBERON:0000925!5.12e-09!118;UBERON:0006595!5.12e-09!118;UBERON:0001007!2.72e-08!116;UBERON:0001555!2.72e-08!116;UBERON:0007026!2.72e-08!116;UBERON:0004921!3.71e-08!114;UBERON:0005911!1.97e-07!69;UBERON:0000926!2.01e-07!120;UBERON:0004120!2.01e-07!120;UBERON:0006603!2.01e-07!120;UBERON:0002530!2.59e-07!65;UBERON:0000063!7.35e-07!35
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.128156,0.612053,0.688265,0.483253,1.67884,0.803568,0.96814,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.928768,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,0.503207,0.089443,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.185353,0.504971,0.0986756,0.675898,0.938241,0.744678,0.949442,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,1.40903,1.75112,1.04072,0.884013,0.362446,1.20828,0.11855,0.129654,0.791209,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,1.85593,0.367176,1.14445,0.938512,0.731844,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,2.77089,1.62879,1.40022,0.839311,1.53196,0.195549,1.56752,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,2.80848,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,1.16191,0.788782,0.0824127
}}
}}

Revision as of 21:12, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr1:173579076..173579119,-p1@Slamf7
Mm9::chr1:173579133..173579143,-p2@Slamf7
Mm9::chr6:48624798..48624832,+p@chr6:48624798..48624832
+
Mm9::chrX:98460743..98460785,-p@chrX:98460743..98460785
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
hemolymphoid system2.04e-1948
immune system2.04e-1948
hematopoietic system1.17e-1845
blood island1.17e-1845
hemopoietic organ4.04e-1729
immune organ4.04e-1729
mixed endoderm/mesoderm-derived structure7.14e-1735
gland of gut1.33e-1324
thymus7.75e-1323
neck7.75e-1323
respiratory system epithelium7.75e-1323
hemolymphoid system gland7.75e-1323
pharyngeal epithelium7.75e-1323
thymic region7.75e-1323
pharyngeal gland7.75e-1323
entire pharyngeal arch endoderm7.75e-1323
thymus primordium7.75e-1323
early pharyngeal endoderm7.75e-1323
pharynx5.64e-1224
upper respiratory tract5.64e-1224
chordate pharynx5.64e-1224
pharyngeal arch system5.64e-1224
pharyngeal region of foregut5.64e-1224
foregut5.92e-1180
respiratory system1.27e-1042
lateral plate mesoderm2.23e-1087
respiratory tract5.48e-1041
segment of respiratory tract8.39e-1027
endoderm-derived structure5.12e-09118
endoderm5.12e-09118
presumptive endoderm5.12e-09118
digestive system2.72e-08116
digestive tract2.72e-08116
primitive gut2.72e-08116
subdivision of digestive tract3.71e-08114
endo-epithelium1.97e-0769
mesoderm2.01e-07120
mesoderm-derived structure2.01e-07120
presumptive mesoderm2.01e-07120
gland2.59e-0765
organ segment7.35e-0735


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:2296&oldid=2563516"